Electroconvulsive therapy in parkinson's disease: A description of three cases;Terapia electroconvulsiva en la enfermedad de parkinson: Descripcion de 3 casos

Neurologia

Volumn 12, Issue 7, 1997, Pages 313-316

  Avila A ^a   Sastre, F ^a   Cardona, X ^a   Maho, P ^a   Bello, J ^a   Sancho, I ^a  

^a Hospital Cruz Roja   (Spain)

Author keywords

Electroconvulsive therapy; Parkinson's disease

Indexed keywords

CLONAZEPAM; LEVODOPA; PERGOLIDE; PRIMIDONE; PROPRANOLOL;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMORBIDITY; DEPRESSION; ELECTROCONVULSIVE THERAPY; FEMALE; HUMAN; MALE; PARKINSON DISEASE;

ANTIPARKINSON AGENTS; CLONAZEPAM; ELECTROCONVULSIVE THERAPY; FEMALE; GABA MODULATORS; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; PROSPECTIVE STUDIES;

EID: 0030876157     PISSN: 02134853     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Lebensohn ZM, Jenkins RB. Improvement of parkinsonism in depressed patients treated with ECT. Am J Psychiatry 1975; 132: 283-285.
2. Brown GC. Parkinsonism, depression and ECT. Am J Psychiatry 1975; 132: 1.084.
3. Asnis G. Parkinson's disease, depression and ECT: a review and case study. Am J Psychiatry 1977; 134: 191-195.
4. Barcia D, Martínez PF. Cuadros depresivos en enfermedad de Parkinson tratados con electroshock. Arch Neurobiol 1978; 41: 393-398.
5. Burke WJ, Peterson J, Rubin EH. Electroconvulsive therapy in the treatment of combined depression and Parkinson's disease. Psychosomatics 1988; 29: 341-346.
6. Hurwitz TA, Calne DB, Waterman K. Treatment of dopaminomimetic psychosis in Parkinson's disease with electroconvulsive therapy. Can J Neurol Sci 1988; 15: 32-34.
7. Douyon R, Serby M, Klutchko B, Rotrosen J. ECT and Parkinson's disease revisited: a "naturalistic" study. Am J Psychiatry 1989; 146: 1.451-1.455.
8. Faber R, Trimble MR. Electroconvulsive theraphy in Parkinson's disease and other movement disorders. Mov Disord 1991; 6: 293-303.
9. Sanz FJ, Tejadas A, Sartorius N, Hernán I. Terapia electroconvulsiva en la enfermedad de Parkinson. Psiquiatría Biológica 1995; 2: 225-234.
10. Balldin J, Eden S, Granerus AK, Modigh K, Svanborg A, Wallinder J et al. Electroconvulsive theraphy in Parkinson's syndrome with "on-off" phenomenon. J Neural Transm 1980; 47: 11-21.
11. Balldin J, Granerus AK, Lindstedt G, Modigh K, Walliner J. Predictors for improvement after electroconvulsive theraphy in parkinsonian patients with "on-off symptoms. J Neural Transm 1981; 52: 199-211.
12. Ward C, Stern GM, Pratt RTC, McKenna P. Electroconvulsive theraphy in parkinsonian patients with the "on-off" syndrome. J Neural Transm 1980; 49: 133-135.
13. Andersen K, Balldin J, Gottfries CG, Granérus AK, Modigh K, Svennerholm L et al. A double-blind evaluation of electroconvulsive therapy in Parkinson's disease with "on-off" phenomena. Acta Neurol Scand 1987; 76: 191-199.
14. Berger M, De Soto DA. The use of ECT for Parkinson symptoms in a nondepressed patient. Psychosomatics 1990; 31: 465-466.
15. Stern MG. Electroconvulsive therapy in untreated Parkinson's disease. Mov Disord 1991; 3: 265.
16. Costain DW, Cowen PJ, Gelder MG, Grahame-Smith DG. Electroconvulsive therapy and the brain: evidence from increased dopamine-mediated responses. Lancet 1982; 2: 400-404.
17. Modigh K, Balldin J, Eriksson E, Granérus AK, Walinder J. Increased responsiveness of dopamine receptors after ECT: a review of experimental and clinical evidence. En: Lerer B, Weiner RD, Belmaker RH, editores. ECT: basic mechanism. Londres: John Libby, 1984; 18-27.
18. Nomikos GG, Zis AP, Damsma G, Fibiger HC. Electroconvulsive shock produces large increases in interstitial concentrations of dopamine in the rat striatum: an in vivo microdialysis study. Neuropsychopharmacology 1991; 4: 65-69.
19. Belmaker RH, Lerer B, Bannet J, Birmaker B. The effect of electroconvulsive shock at a clinically equivalent schedule on rat cortical beta-adrenoreceptors. J Clin Pharmacol 1982; 34: 275.
20. Green AR, Sant K, Bowdler JM, Cowen PJ. Further evidence for a relationship between changes in GABA concentration in rat brain and enhaced monoamine activated behaviours following repeated electroconvulsive shock. Neuropharmacology 1982; 21: 981-984.
21. American Psychiatric Association Task Force on Electroconvulsive Therapy. The practice of electroconvulsive therapy: recomendations for treatment, training and privileging. Washington: American Psychiatric Association, 1990.
22. Fahn S, Elston RL and members of the UPDRS development committee. Unified Parkinson's disease rating scale. En: Fahn S, Marsden CD, Goldstein M, Calne DB, editores. Recent developments in Parkinson's disease. Vol. 2. Nueva York: MacMilan, 1987; 153-163.
23. Oh J, Rummans T, O'Connor K, Ahlskog E. Cognitive impairment after ECT in patients with Parkinson's disease and psychiatric illness. Am J Psychiatry 1992; 149: 2.271.
24. Rasmussen K, Abrams R. Treatment of Parkinson's disease with ECT. Psychiatr Clin North Am 1991; 14: 925-933.
25. Wilder J. Parkinsonism, depression and ECT. Am J Psychiatry 1975; 132: 1.083-1.084.
26. Jaeckle RS, Disalver SC. Covariation of depressive symptoms, parkinsonism, and post-dexamethasone plasma cortisol levels in a bipolar patient: simultanenous response to ECT and lithium carbonate. Acta Psych Scand 1986; 74: 68-72.
27. Atre-Vaidya N, Jampala VC. Electroconvulsive therapy in parkinsonism with affective disorder. Br J Psychiatry 1988; 152: 55-58.
28. Roth SD, Mukherjee S, Sackeim HA. Electroconvulsive therapy in a patient with mania, parkinsonism, and tardive dyskinesia. Convulsive Ther 1988; 4: 92-97.